125 related articles for article (PubMed ID: 35622180)
1. Albumin and Derived Neutrophil-to-Lymphocyte Ratio is a Novel Prognostic Factor for Patients with Esophageal Squamous Cell Carcinoma.
Abe T; Oshikiri T; Goto H; Kato T; Horikawa M; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Nakamura T; Kakeji Y
Ann Surg Oncol; 2022 Oct; 29(11):6860-6866. PubMed ID: 35622180
[TBL] [Abstract][Full Text] [Related]
2. Albumin-Derived NLR Score is a Novel Prognostic Marker for Esophageal Squamous Cell Carcinoma.
Abe T; Oshikiri T; Goto H; Kato T; Horikawa M; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Kakeji Y
Ann Surg Oncol; 2022 Apr; 29(4):2663-2671. PubMed ID: 34807322
[TBL] [Abstract][Full Text] [Related]
3. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
Fu X; Li T; Dai Y; Li J
BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
[TBL] [Abstract][Full Text] [Related]
4. The prognostic role of the change in albumin-derived neutrophil-to-lymphocyte ratio during neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Pan Z; Wang Y; Li S; Cai H; Guan G
Biomol Biomed; 2024 May; 24(3):612-624. PubMed ID: 38041687
[TBL] [Abstract][Full Text] [Related]
5. The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy.
Gao QF; Qiu JC; Huang XH; Xu YM; Li SQ; Sun F; Zhang J; Yang WM; Min QH; Jiang YH; Chen QG; Zhang L; Wang XZ; Ying HQ
Cancer Cell Int; 2018; 18():153. PubMed ID: 30305803
[TBL] [Abstract][Full Text] [Related]
6. The pretherapeutic systemic inflammation score is a prognostic predictor for elderly patients with oesophageal cancer: a case control study.
Huang C; Wang M; Chen L; Wang H; Huang D; Shi J; Zhang W; Tian Y; Zhu Y
BMC Cancer; 2023 Jun; 23(1):505. PubMed ID: 37270496
[TBL] [Abstract][Full Text] [Related]
7. Alb-dNLR Score as a Novel Prognostic Marker for Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy.
Nakanishi T; Matsuda T; Yamashita K; Hasegawa H; Sawada R; Harada H; Urakawa N; Goto H; Kanaji S; Oshikiri T; Kakeji Y
Anticancer Res; 2024 Jan; 44(1):229-237. PubMed ID: 38159989
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy.
Cox S; Hurt C; Grenader T; Mukherjee S; Bridgewater J; Crosby T
Radiother Oncol; 2017 Oct; 125(1):154-159. PubMed ID: 28893415
[TBL] [Abstract][Full Text] [Related]
9. A novel inflammation-based prognostic index for patients with esophageal squamous cell carcinoma: Neutrophil lymphocyte ratio/prealbumin ratio.
Lv Y; Zhang J; Liu Z; Tian Y; Liu F
Medicine (Baltimore); 2019 Feb; 98(7):e14562. PubMed ID: 30762804
[TBL] [Abstract][Full Text] [Related]
10. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
Ji WH; Jiang YH; Ji YL; Li B; Mao WM
Dis Esophagus; 2016 Jul; 29(5):403-11. PubMed ID: 25625421
[TBL] [Abstract][Full Text] [Related]
11. Baseline derived neutrophil-to-lymphocyte ratio as a prognostic biomarker for non-colorectal gastrointestinal cancer patients treated with immune checkpoint blockade.
Li S; Zou J; Liu C; Jiao X; Gong J; Li J; Wang Z; Lu M; Lu Z; Shen L
Clin Immunol; 2020 Mar; 212():108345. PubMed ID: 31953149
[TBL] [Abstract][Full Text] [Related]
12. Circulating CEA-dNLR score predicts clinical outcome of metastatic gallbladder cancer patient.
Du JH; Lu J
J Clin Lab Anal; 2019 Feb; 33(2):e22684. PubMed ID: 30461064
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer.
Yamada Y; Sakamoto S; Rii J; Yamamoto S; Kamada S; Imamura Y; Nakamura K; Komiya A; Nakatsu H; Ichikawa T
Prostate; 2020 May; 80(7):559-569. PubMed ID: 32134137
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma.
Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z
J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein to albumin ratio is a prognostic factor for patients with cStage II/III esophageal squamous cell cancer.
Otowa Y; Nakamura T; Yamamoto M; Kanaji S; Matsuda Y; Matsuda T; Oshikiri T; Sumi Y; Suzuki S; Kakeji Y
Dis Esophagus; 2017 Dec; 30(12):1-5. PubMed ID: 28881893
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of platelet-to-albumin ratio in patients with esophageal squamous cell carcinoma receiving definitive radiotherapy.
Huang Z; Zheng Q; Yu Y; Zheng H; Wu Y; Wang Z; Liu L; Zhang M; Liu T; Li H; Li J
Sci Rep; 2022 Mar; 12(1):3535. PubMed ID: 35241740
[TBL] [Abstract][Full Text] [Related]
17. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients.
Absenger G; Szkandera J; Pichler M; Stotz M; Arminger F; Weissmueller M; Schaberl-Moser R; Samonigg H; Stojakovic T; Gerger A
Br J Cancer; 2013 Jul; 109(2):395-400. PubMed ID: 23820252
[TBL] [Abstract][Full Text] [Related]
18. A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma.
Xu XL; Yu HQ; Hu W; Song Q; Mao WM
PLoS One; 2015; 10(9):e0138657. PubMed ID: 26390126
[TBL] [Abstract][Full Text] [Related]
19. The association between albumin-dNLR score and disease activity in patients with rheumatoid arthritis.
Chen S; Ying H; Du J; Zhu X; Shi J; Zhang Y; Chen S; Shen B; Li J
J Clin Lab Anal; 2019 Mar; 33(3):e22695. PubMed ID: 30320486
[TBL] [Abstract][Full Text] [Related]
20. Albumin-derived Neutrophil-to-Lymphocyte Ratio Score as a Marker of Nivolumab Treatment Sensitivity in Gastric Cancer: A Multicenter Study.
Nakazawa N; Sohda M; Tateno K; Watanabe T; Kimura A; Kogure N; Hosaka H; Naganuma A; Sekiguchi M; Saito K; Ogata K; Sano A; Sakai M; Ogawa H; Shirabe K; Saeki H
In Vivo; 2023; 37(2):818-824. PubMed ID: 36881071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]